Primary weight loss failure after Roux-en-Y gastric bypass is characterized by impaired gut-hormone mediated regulation of food intake.
Journal Information
Full Title: Int J Obes (Lond)
Abbreviation: Int J Obes (Lond)
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Competing interests CM has received support from Novo Nordisk A/S for organizing/attending meetings. JEBJ and SST have received research grants and lecture fees from Novo Nordisk A/S. CD has served as advisor for Novo Nordisk A/S and AstraZeneca and received lecture fees from Novo Nordisk A/S. NBJ has served on advisory panels and in educational programs from Novo Nordisk A/S, has received research support from Boehringer Ingelheim Denmark. In addition, NBJ reports having taken a position with Novo Nordisk A/S as of March 2023. The remaining authors have no competing interests related to this study."
"Funding Open access funding provided by Royal Library, Copenhagen University Library."
"Eligible patients were identified using a database of > 600 patients operated with RYGB at Copenhagen University Hospital Hvidovre, Denmark in 2012–2015. Patients with primary WL failure (LowEBMIL, n = 20) were defined by postoperative EBMIL < 50% at all visits including 1 and 2 years postoperatively after uncomplicated RYGB. Each patient in the primary WL failure group was matched individually with one patient with successful WL (postoperative EBMIL > 60%, HighEBMIL, n = 20) with respect to age, preoperative BMI and time from RYGB. Only women without a history of diabetes (Hba1c < 48 mmol/mol without glucose-lowering medication) were included. Exclusion criteria were unstable weight (self-reported > ±3 kg in 3 months), inadequately treated hypothyroidism, use of antithyroid medication or medication affecting appetite, hemoglobin < 6.5 mmol/L, pregnancy/breastfeeding or unwillingness/allergies toward the test meals. The study was approved by the Regional Ethical Committee of the Capital Region (H-4–2014–007), by the Danish Data Protection Agency and was performed in accordance with the Helsinki declaration and registered at ClinicalTrials.gov (NCT02344632). Written informed consent was obtained from all participants before inclusion."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025